The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline pathogenic/likely pathogenic (P/LP) variants in epithelial neuroendocrine neoplasms: The case for universal germline genetic testing.
 
Udhayvir Grewal
No Relationships to Disclose
 
Brittany Sears
No Relationships to Disclose
 
Matthew Gao
No Relationships to Disclose
 
Cassidy Carraway
Employment - Ambry Genetics
 
Seth Concors
No Relationships to Disclose
 
Po Ear
No Relationships to Disclose
 
Olatunji Alese
Employment - Emory University
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Civala; CUE Biopharma; Exelixis; Ipsen; Loxo/Lilly; Revolution Medicines; Taiho Oncology; Takeda
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - COMPASS THERAPEUTICS, INC
 
Andrew Bellizzi
No Relationships to Disclose
 
Chandrikha Chandrasekharan
Consulting or Advisory Role - Curium Pharma; Exelixis
 
Renuka Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bayer; Eisai; Exelixis; Genentech; Incyte; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sandoz; Sun pharma; Tersera
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - AstraZeneca; Genentech; Replimune
 
Jennifer Chan
Stock and Other Ownership Interests - Merck
Honoraria - Ipsen
Consulting or Advisory Role - Boehringer Ingelheim; Curium Pharma; Lantheus Medical Imaging; Pfizer (I)
Research Funding - Camurus; Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from UpToDate for authorship
Travel, Accommodations, Expenses - Ipsen
 
Simron Singh
Employment - Sanofi (I)
Honoraria - Advanced Accelerator Applications/Novartis; IPSEN
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Camurus; IPSEN; ITM Isotope Technologies Munich; McKesson; Sanofi
 
Daniel Halperin
Consulting or Advisory Role - Abbvie; Amryt Pharma; Boehringer Ingelheim; Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Exelixis; Harbour BioMed; Harpoon therapeutics; Ipsen; Isotopen Technologien; Lantheus Medical Imaging; Novartis; Progenics; Radiomedix; Sanofi Aventis GmbH; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Chimeric Therapeutics (Inst); Crinetics Pharmaceuticals (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); RayzeBio (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)